Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

First selective, irreversible N-SMase inhibitor designed by German university researchers

June 29, 2000

Atrix and Elan form partnership focused on oncology and pain management

June 29, 2000

Aventis and Millennium establish alliance for antiinflammatory drugs and drug discovery technologies

June 28, 2000

Noninvasive technique for delivering therapeutic genes to the brain

June 27, 2000

AVI BioPharma and DepoMed explore oral delivery of AVI's antisense agents

June 26, 2000

Genta and Molecular Biosystems establish licensing agreement for antisense technology

June 21, 2000

Celera Genomics and Geron to collaborate on human pluripotent stem cell genomics

June 20, 2000

MorphoSys licenses HuCAL technology to Eos Biotechnology

June 19, 2000

Ibis Therapeutics and Agouron embark on drug discovery collaboration

June 19, 2000

Cambridge Drug Discovery awarded European grant

June 16, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...